MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 172 filers reported holding MERIDIAN BIOSCIENCE INC in Q2 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $231,000 | -28.5% | 16,760 | -8.2% | 0.02% | -36.0% |
Q4 2016 | $323,000 | -60.6% | 18,260 | -57.0% | 0.02% | -60.3% |
Q3 2016 | $820,000 | -17.9% | 42,510 | -12.3% | 0.06% | -27.6% |
Q1 2016 | $999,000 | -9.8% | 48,450 | -10.2% | 0.09% | -11.2% |
Q4 2015 | $1,107,000 | +11.4% | 53,950 | -7.2% | 0.10% | -4.9% |
Q3 2015 | $994,000 | -9.6% | 58,150 | -1.4% | 0.10% | -1.9% |
Q2 2015 | $1,099,000 | -2.3% | 58,950 | 0.0% | 0.10% | -5.4% |
Q1 2015 | $1,125,000 | +16.0% | 58,950 | 0.0% | 0.11% | +5.7% |
Q4 2014 | $970,000 | -58.5% | 58,950 | -55.4% | 0.10% | -61.4% |
Q3 2014 | $2,336,000 | -14.3% | 132,050 | 0.0% | 0.27% | -11.1% |
Q2 2014 | $2,726,000 | -5.2% | 132,050 | 0.0% | 0.31% | -9.7% |
Q1 2014 | $2,877,000 | -14.0% | 132,050 | +4.8% | 0.34% | -18.1% |
Q4 2013 | $3,344,000 | +12.3% | 126,050 | 0.0% | 0.41% | +3.5% |
Q3 2013 | $2,979,000 | +9.9% | 126,050 | 0.0% | 0.40% | -1.7% |
Q2 2013 | $2,710,000 | – | 126,050 | – | 0.41% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Acuitas Investments, LLC | 283,983 | $6,299,000 | 3.15% |
Euclidean Technologies Management, LLC | 128,088 | $2,841,000 | 2.26% |
GLOBEFLEX CAPITAL L P | 185,939 | $4,124,000 | 0.74% |
HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,194,000 | 0.66% |
CLARK ESTATES INC/NY | 220,000 | $4,880,000 | 0.64% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,424,274 | $31,590,000 | 0.56% |
SYSTEMATIC FINANCIAL MANAGEMENT LP | 789,827 | $17,518,000 | 0.53% |
EARNEST PARTNERS LLC | 3,885,748 | $86,186,000 | 0.51% |
MOODY ALDRICH PARTNERS LLC | 137,075 | $3,040,000 | 0.43% |
VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | 414,323 | $9,190,000 | 0.33% |